Addressing a Treatment Gap

This publication has 15 references indexed in Scilit:

• Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
  JAMA, 2001
• Lipid-Altering Efficacy and Safety of Simvastatin 80 mg/Day: Long-Term Experience in a Large Group of Patients with Hypercholesterolemia
  Clinical Cardiology, 2000
• MRC/BHF Heart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience
  Published by Oxford University Press (OUP) ,1999
• Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels
  JAMA, 1998
• EUROASPIRE: A European Society of Cardiology survey of secondary prevention of coronary heart disease: Principal results
  European Heart Journal, 1997
• Preventing heart attack and death in patients with coronary disease
  Journal of the American College of Cardiology, 1995
• Treatment with beta-adrenergic blocking agents after myocardial infarction: From randomized trials to clinical practice
  Journal of the American College of Cardiology, 1995
• Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
  JAMA, 1993
• Effects of Simvastatin and Cholestyramine in Familial and Nonfamilial Hypercholesterolemia
  Archives of internal medicine (1960), 1990
• Effects of simvastatin and probucol in hypercholesterolemia (simvastatin multicenter study group II)
  The American Journal of Cardiology, 1989